Ramsay Santé - Public Comps and Valuation Multiples

Ramsay Santé Overview

About Ramsay Santé

Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.

Founded

1987

HQ

Employees

34K+

Website

ramsaygds.fr

Sectors

Hospitals & Clinics

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$5.2B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Ramsay Santé Financials

Ramsay Santé has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Ramsay Santé achieved revenue of $5.4B and an EBITDA of $628M.

Ramsay Santé expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Ramsay Santé valuation multiples based on analyst estimates

Ramsay Santé P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$5.0B	$5.4B	XXX	XXX	XXX
Gross Profit	$3.7B	$4.0B	XXX	XXX	XXX
Gross Margin	73%	74%	XXX	XXX	XXX
EBITDA	$693M	$628M	XXX	XXX	XXX
EBITDA Margin	14%	12%	XXX	XXX	XXX
Net Profit	$127M	$53.1M	XXX	XXX	XXX
Net Margin	3%	1%	XXX	XXX	XXX
Net Debt	$1.8B	$1.8B	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Ramsay Santé Stock Performance

As of April 15, 2025, Ramsay Santé's stock price is EUR 10 (or $10).

Ramsay Santé has current market cap of EUR 1.1B (or $1.1B), and EV of EUR 4.8B (or $5.2B).

See Ramsay Santé trading valuation data

Ramsay Santé Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$5.2B	$1.1B	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Ramsay Santé Valuation Multiples

As of April 15, 2025, Ramsay Santé has market cap of $1.1B and EV of $5.2B.

Ramsay Santé's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Ramsay Santé's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Ramsay Santé and 10K+ public comps

Ramsay Santé Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$5.2B	XXX	XXX	XXX
EV/Revenue	n/a	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	XXX	XXX
P/E	n/a	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	n/a	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Ramsay Santé Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Ramsay Santé Valuation Multiples

Ramsay Santé's NTM/LTM revenue growth is n/a

Ramsay Santé's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Ramsay Santé's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Ramsay Santé's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Ramsay Santé and other 10K+ public comps

Ramsay Santé Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	6%	XXX	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	XXX	XXX	XXX
EBITDA Growth	-9%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	$0.2M	XXX	XXX	XXX	XXX
Opex per Employee	$0.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	75%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry